Three points Fauci makes, paraphrased here: We [the Administration] were told right in the Situation Room that there would be a shortage of masks, because people were going to buy N95’s. We did not want to create a situation where health care providers wouldn’t get those masks. There was no real evidence (at the time) …
Continue reading “Why Fauci Advised Against Wearing a Mask Early in the Pandemic”
Questioning the source of that article, though, reveals gems such as this: Why don’t we let kids knife fight like the good old days? Firing Squads Are Honest, At Least Right. He doesn’t seem to mind when other states are accused of manipulating COVID data, either. I don’t see any deep investigative work here, Once …
From Charles C.W. Cooke at National Review: At the time she was hired, the state government knew from its background check that Jones had completed a pre-trial intervention program in Louisiana in 2018, thereby securing a “no conviction” record for “battery of a police officer,” and it knew that she had entered into a deferred-prosecution …
Continue reading “Rebekah Jones, the COVID Whistleblower Who Wasn’t”
From this Medium article I’m forced to quote because I spend too much time criticizing John Gruber and Daring Fireball: Now, you might look at this story [the two-week vaccine pause] and assume that, as they say, “The system worked.” But it’d be more accurate to say that the system worked as it’s designed to …
Continue reading “Cost Benefit Analysis of J&J Vaccine Pause”
From The Washington Post: At its meeting, ACIP analyzed vaccine side effects with admirable transparency. But there was no rigorous analysis of the risks of not being vaccinated. Rather, ACIP insisted that because “alternative covid-19 vaccines (mRNA vaccines) are available,” the tradeoffs are inconsequential. This shows a profound disconnect with the reality many Americans face. …
From The Verge: Vaccinations with the Johnson & Johnson shot could start back up as soon as tomorrow morning, said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, during a press briefing.
From YouGov: Comparing the results from those who took the survey before the announcement with those who took the survey afterward shows the huge impact the CDC’s decision has had on the perceived safety of the Johnson & Johnson vaccine. Among those who started the survey before the announcement about the Johnson & Johnson vaccine …
Looking back at what I wrote yesterday, I had been mulling the various options: Say nothing, do nothing. Don’t announce the investigation into the blood clots, don’t pause the vaccine. Say something, do nothing. Announce you’re investigating, but don’t pause the vaccine. Say nothing, do something. Don’t publicly announce it, but quietly tell states not …
From The New York Times: Injections of Johnson & Johnson’s coronavirus vaccine came to a sudden halt across the country on Tuesday after federal health agencies called for a pause in the vaccine’s use as they examine a rare blood-clotting disorder that emerged in six recipients. Which has led to some very bad hot takes: …
Continue reading “U.S. Calls for Pause on Johnson & Johnson Vaccine After Blood Clotting Cases”
This entire article is a great read, but I came across something below I had not heard before. From Bloomberg: Pfizer executives found a partial fix to their supply problem in the vaccine vials themselves. They just needed authorization to change the labels to say the vials contained six doses instead of five. It’s standard …
Continue reading “Inside Pfizer’s Fast, Fraught, and Lucrative Vaccine Distribution”